Keywords

Arabic translation, Cancer Behavior Inventory-Brief, Cancer patients, Cognitive interview, Functional Assessment of Cancer Therapy, Quality of life, Reliability, Self-efficacy for coping, Validity, Women with breast cancer

 

Authors

  1. Algamdi, Maaidah M. PhD, RN
  2. Hanneman, Sandra K. PhD, RN, FAAN

Abstract

Background: Valid and reliable instruments in Arabic are needed to measure self-efficacy and quality of life for Arabic patients with cancer.

 

Objective: The aim of this study was to test the psychometric performance of the Cancer Behavior Inventory-Brief Arabic (CBI-BA), including participant understanding of items, and the Functional Assessment of Cancer Therapy-Breast Arabic (FACT-BA).

 

Methods: Using a cross-sectional design, 438 cancer patients completed the CBI-BA, 30 of whom completed cognitive interviews. A subsample 167 women with breast cancer also completed the FACT-BA. Internal consistency evidence was assessed with Cronbach's [alpha] and construct validity with principal axis factoring.

 

Results: Internal consistency estimates were acceptable for the total CBI-BA ([alpha] = .81) and FACT-BA ([alpha] = .88) scales. Exploratory factor analyses showed evidence of construct validity for the CBI-BA; 1 factor was derived, compared with four in the original English version. Cognitive interviews indicated satisfactory patient understanding of CBI-BA items. The Arabic version of the general FACT-General scale had 4 factors according to expectation.

 

Conclusion: The CBI-BA has adequate psychometric performance for the measurement of self-efficacy for coping with cancer in Arabic patients. The FACT-General Arabic has adequate evidence of reliability and validity for the measurement of quality of life in Arabic women with breast cancer.

 

Implications for Practice: The availability of culturally sensitive and psychometrically sound instruments for Arabic patients diagnosed with cancer should be valuable for healthcare clinicians and researchers to assess self-efficacy for coping with cancer and quality of life.